Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Head and Neck Cancer”

1,328 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,328 results

Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Weijia Fang, MD 43
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Not applicableStudy completedNCT04776837
What this trial is testing

Predicting Disease Progression and/or Recurrence in Cancer

Who this might be right for
Patient Reported Outcome MeasuresColorectal CancerPancreatic Cancer+5 more
Massachusetts General Hospital 200
Early research (Phase 1)Study completedNCT00003430
What this trial is testing

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Head and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Large-scale testing (Phase 3)Ended earlyNCT04458909
What this trial is testing

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Keratinizing Squamous Cell CarcinomaMetastatic Nasopharyngeal Nonkeratinizing Carcinoma+8 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT00690872
What this trial is testing

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Testing effectiveness (Phase 2)Looking for participantsNCT06876844
What this trial is testing

Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 24
Testing effectiveness (Phase 2)Looking for participantsNCT07213934
What this trial is testing

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerRecurrent Head and Neck Squamous Cell Carcinoma
University of Cincinnati 40
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Early research (Phase 1)Study completedNCT00243347
What this trial is testing

The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

Who this might be right for
CarcinomaNon-Small-Cell Lung CarcinomaHead and Neck Neoplasms
AstraZeneca 19
Testing effectiveness (Phase 2)UnknownNCT03096184
What this trial is testing

Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT05909904
What this trial is testing

Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
BeiGene 160
Large-scale testing (Phase 3)Ended earlyNCT00088907
What this trial is testing

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
National Cancer Institute (NCI) 270
Testing effectiveness (Phase 2)Study completedNCT02268695
What this trial is testing

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Groupe Oncologie Radiotherapie Tete et Cou 541
Post-approval studies (Phase 4)UnknownNCT04683575
What this trial is testing

Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma

Who this might be right for
Selenium DeficiencyThyroid Cancer TNM StagingRecurrence+1 more
Qianfoshan Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00016900
What this trial is testing

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT03183115
What this trial is testing

RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection

Who this might be right for
Esophageal Squamous Cell Neoplasm
E-DA Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00387335
What this trial is testing

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+11 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Load More Results